COM:CARIBOUBIO
Caribou Biosciences
- Stock
Last Close
1.98
22/11 21:00
Market Cap
182.92M
Beta: -
Volume Today
989.16K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 2.81M - | -14.34M 610.74% | -46.84M 226.67% | -31.29M 33.21% | ||
average payables | 2.57M - | 3.30M 28.28% | 2.57M 22.08% | 2.13M 16.94% | ||
average receivables | 4.57M - | 6.64M 45.31% | 6.39M 3.73% | 3.55M 44.49% | ||
book value per share | 0.27 - | -0.85 414.04% | 12.25 1,545.41% | 4.95 59.60% | 0.00 99.90% | |
capex per share | -0.03 - | -0.05 48.76% | -0.10 107.31% | -0.12 17.70% | -0.00 99.86% | |
capex to depreciation | -1.18 - | -1.46 24.13% | -3.17 117.08% | -4.35 37.12% | -3.29 24.25% | |
capex to operating cash flow | 0.03 - | 0.04 43.34% | 0.10 142.42% | 0.08 19.20% | 0.12 60.53% | |
capex to revenue | -0.15 - | -0.11 30.35% | -0.33 205.66% | -0.51 56.62% | -0.34 33.86% | |
cash per share | 1.79 - | 0.58 67.75% | 11.87 1,957.82% | 4.07 65.68% | 0.00 99.89% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | 251.11 - | 152.37 39.32% | 308.95 102.77% | 122.91 60.22% | 25.77 79.03% | |
debt to assets | 0.69 - | 0.04 93.66% | 0.03 25.41% | 0.07 127.33% | 0.06 15.51% | |
debt to equity | 5.73 - | -0.07 101.18% | 0.04 155.32% | 0.09 147.59% | 0.07 20.21% | |
dividend yield | ||||||
earnings yield | -0.05 - | -0.08 46.42% | -0.14 84.28% | -0.26 85.90% | -0.00 99.91% | |
enterprise value | 410.83M - | 436.99M 6.37% | 237.38M 45.68% | 351.24M 47.97% | 422.89B 120,300.45% | |
enterprise value over ebitda | -12.64 - | -12.68 0.30% | -3.48 72.53% | -3.31 5.07% | -3.64K 110,141.12% | |
ev to operating cash flow | -12.84 - | -13.16 2.50% | -7.30 44.52% | -3.86 47.10% | -4.53K 117,299.83% | |
ev to sales | 70.98 - | 35.35 50.19% | 24.73 30.04% | 25.36 2.53% | 12.27K 48,270.41% | |
free cash flow per share | -1.19 - | -1.25 4.99% | -1.13 9.84% | -1.61 43.23% | -0.00 99.91% | |
free cash flow yield | -0.07 - | -0.08 4.99% | -0.07 2.49% | -0.26 244.15% | -0.00 99.90% | |
graham net net | -0.02 - | -1.39 9,020.64% | 9.85 808.54% | 2.42 75.45% | 0.00 99.85% | |
graham number | 2.27 - | 4.86 114.44% | 24.13 396.26% | 13.49 44.09% | 0.01 99.91% | |
income quality | 1.37 - | 0.97 29.12% | 0.49 49.81% | 0.91 88.30% | 0.91 0.11% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -8.58K - | -1.81K 78.94% | -8.37K 363.54% | 12.46 100.15% | ||
interest debt per share | 1.55 - | 0.06 96.26% | 0.46 690.02% | 0.32 30.79% | 0.00 99.88% | |
inventory turnover | ||||||
invested capital | 5.73 - | -0.07 101.18% | 0.04 155.32% | 0.09 147.59% | 0.07 20.21% | |
market cap | 451.37M - | 451.37M 0% | 477.80M 5.86% | 381.83M 20.09% | 422.92B 110,660.36% | |
net current asset value | 2.54M - | -35.18M 1,486.01% | 336.66M 1,057.05% | 187.35M 44.35% | 275.03M 46.80% | |
net debt to ebitda | 1.25 - | 0.42 66.56% | 3.53 745.69% | 0.29 91.84% | 0.21 28.01% | |
net income per share | -0.85 - | -1.24 46.42% | -2.11 70.39% | -1.64 22.63% | -0.00 99.92% | |
operating cash flow per share | -1.16 - | -1.20 3.78% | -1.03 14.48% | -1.50 45.68% | -0.00 99.92% | |
payables turnover | ||||||
receivables turnover | 1.45 - | 2.40 64.81% | 1.18 50.68% | 2.97 151.37% | 14.16 376.96% | |
research and ddevelopement to revenue | 4.08 - | 2.78 31.80% | 5.44 95.49% | 5.94 9.04% | 3.25 45.24% | |
return on tangible assets | -0.38 - | -0.95 151.58% | -0.15 84.10% | -0.27 75.82% | -0.24 11.22% | |
revenue per share | 0.21 - | 0.45 113.56% | 0.30 32.18% | 0.23 24.85% | 0.00 99.79% | |
roe | -3.14 - | 1.46 146.62% | -0.17 111.79% | -0.33 91.50% | -0.28 16.15% | |
roic | -0.52 - | 1.57 403.64% | -0.17 110.66% | -0.30 78.58% | -0.28 7.91% | |
sales general and administrative to revenue | 2.84 - | 1.14 60.00% | 2.53 122.79% | 2.74 8.32% | 1.12 59.36% | |
shareholders equity per share | 0.27 - | -0.85 414.04% | 12.25 1,545.41% | 4.95 59.60% | 0.00 99.90% | |
stock based compensation to revenue | 0.21 - | 0.08 61.98% | 0.36 343.30% | 0.85 135.39% | 0.40 52.85% | |
tangible asset value | 7.46M - | -23.44M 414.04% | 387.82M 1,754.76% | 300.87M 22.42% | 368.40M 22.44% | |
tangible book value per share | 0.27 - | -0.85 414.04% | 12.25 1,545.41% | 4.95 59.60% | 0.00 99.90% | |
working capital | 46.93M - | 11.92M 74.61% | 365.36M 2,965.90% | 232.12M 36.47% | 310.54M 33.78% |
All numbers in (except ratios and percentages)